Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Castle Biosciences Fourth Quarter and Full Year 2025 Earnings Call - TissueCypher Momentum and AdvanceAD Early Traction Set the Stage While Margin and Guideline Headwinds Persist
Castle closed 2025 with strong top-line momentum driven by TissueCypher’s 86% volume jump and steady DecisionDx-Melanoma growth, while launching AdvanceAD-Tx into limited access where early clinician ...
- Total revenue for 2025 was $344.2 million, with Q4 revenue of $87.0 million, exceeding guidance.
- TissueCypher test reports jumped 86% in 2025 to 39,014 reports; patient penetration exiting 2025 is roughly 11%, clinician penetration about 25-30% suggesting a large runway.
- DecisionDx-Melanoma delivered 39,083 test reports in 2025, up 9% year-over-year, with patient penetration near 31% and total ordering clinicians approaching 17,000 lifetime.
- +12 more takeaways
Puma Biotechnology Q4 2025 Earnings Call - Nerlynx sales inch up as inventory and China royalty boost results, alisertib trials accelerate
Puma posted a modest quarter where headline revenue gains mask a familiar pattern, inventory builds and a one-time royalty payout did a lot of the heavy lifting. NERLYNX net product revenue rose to $5...
- Total revenue for Q4 2025 was $75.5 million, with NERLYNX net product revenue of $59.9 million and royalty revenue of $15.6 million.
- Q4 NERLYNX product revenue rose versus Q3 2025 ($51.9 million) and Q4 2024 ($54.4 million), driven in part by a $5.7 million inventory build at specialty pharmacies and distributors.
- NERLYNX ex-factory bottle sales were 3,298 in Q4 2025, up roughly 12% quarter-over-quarter and 11% year-over-year; estimated inventory increased by about 343 bottles in Q4.
- +13 more takeaways
OrthoPediatrics Corp. Q4 2025 Earnings Call - Hit first quarterly free cash flow positive, guiding to 2026 FCF breakeven with double-digit growth
OrthoPediatrics closed 2025 with broad-based momentum: Q4 revenue rose 17% to $61.6 million, full-year revenue grew 15%, adjusted EBITDA improved sharply and the company reported its first-ever quarte...
- Q4 2025 revenue $61.6 million, up 17% year-over-year; full-year 2025 revenue up 15%.
- Q4 adjusted EBITDA was $4.8 million, a 59% improvement versus Q4 2024; management says full-year 2025 adjusted EBITDA rose nearly 75% year-over-year.
- Company generated $10 million of free cash flow in Q4, its first quarter of positive FCF in company history; full-year cash usage improved to $15 million from $41 million in 2024.
- +10 more takeaways
Korea Electric Power Corporation Q4 2025 Earnings Call - FY2025 profit lifted by lower fuel costs and higher nuclear output, but Q4 clouded by volatile provisions and subsidiary costs
KEPCO reported consolidated FY2025 operating income of KRW 13,524.8 billion and net income of KRW 8,737.2 billion, driven by a 4.3% rise in revenue and a sharp drop in fuel costs. Fuel and purchased-p...
- FY2025 consolidated operating income: KRW 13,524.8 billion (KRW 13.5248 trillion).
- FY2025 consolidated revenue: KRW 97,434.5 billion, up 4.3% year-over-year; power sales KRW 93,004.6 billion, up 4.6%.
- FY2025 consolidated net income: KRW 8,737.2 billion.
- +16 more takeaways
Banco Macro 4Q 2025 Earnings Call - Profit Rebound Masked by ARS 82.9bn Restructuring, Adjusted ROE Target ~8% for 2026
Banco Macro returned to profitability in 4Q25, but the headline masks a heavy reset. Reported net income was ARS 100 billion in the quarter after ARS 82.9 billion of restructuring and severance charge...
- Reported 4Q25 net income was ARS 100 billion, recovering from the prior quarter loss, but 26% below 4Q24.
- Excluding ARS 82.9 billion of restructuring and severance charges, 4Q25 net income would be ARS 183 billion; FY25 adjusted net income would be ARS 393.7 billion.
- Bank recorded ARS 82.9 billion of restructuring expenses in 4Q25, with about ARS 36 billion of related personnel exits impacting 2026, and management expects similar items to appear across early 2026.
- +13 more takeaways
Ducommun Incorporated Q4 2025 Earnings Call - Record Margins and Big Missile Orders Push Defense-Led Growth
Ducommun closed Q4 2025 with a new revenue record of $215.8 million, stronger margins and a missile-booking surge that underpins managements claim that VISION 2027 is on track. Gross margin hit 27.7% ...
- Q4 2025 revenue hit a record $215.8 million, up 9.4% year over year and the 19th consecutive quarter of year over year growth.
- Adjusted gross margin was 27.7% in Q4, up from 24.0% on an adjusted basis in Q4 2024; about 100 basis points of the quarter's margin benefit came from favorable product mix.
- Adjusted EBITDA reached a record 17.5% ($37.9 million) in Q4 2025, up $10.6 million versus Q4 2024; management still views a blended 2026 EBITDA baseline near 16.5% after removing mix effects.
- +13 more takeaways
Sempra Energy Q4 2025 Earnings Call - $65B CapEx Plan Pivots Sempra to Texas Transmission-Led, 95% Regulated Utility with No Equity Needs
Sempra used the Q4 2025 call to declare a strategic pivot. Management launched a record $65 billion 2026-2030 capital plan, largely concentrated in Texas transmission, and argued the company can fund ...
- Sempra delivered record full-year 2025 adjusted EPS of $4.69, at the high end of its guidance range; Q4 2025 adjusted EPS was $1.28 (GAAP Q4 $0.54).
- Management unveiled a $65 billion capital plan for 2026-2030, a 17% increase versus last year, with roughly 95% of spend targeted to regulated utility investments.
- Oncor/Texas drives the plan, with Sempra Texas rate base projected to grow at an 18% CAGR 2026-2030; overall company rate base is expected to rise from $57 billion in 2025 to $97 billion in 2030, an 11% CAGR.
- +12 more takeaways
HEICO Corporation Q1 2026 Earnings Call - Record earnings and strategic push into industrial gas turbines
HEICO posted a clean, profitable quarter: consolidated net income rose 13% to a record $190.2 million, or $1.35 per diluted share, with net sales up 14% and consolidated EBITDA up 14% to $312 million....
- Record Q1 net income of $190.2 million, up 13%, or $1.35 per diluted share; discrete stock option tax benefit was $21.8 million, lower than prior year’s $26.5 million.
- Consolidated net sales rose 14% and operating income increased 15%; consolidated EBITDA grew 14% to $312 million.
- Flight Support Group (FSG) led the quarter: net sales up 15% to $820 million, operating income up 21% to $200.7 million, and operating margin improved to 24.5% (cash EBITA margin ~27.1%).
- +12 more takeaways
The Pennant Group Fourth Quarter 2025 Earnings Call - 2026 Guidance Set Around Integration of Large Southeast Acquisition
Pennant closed 2025 with revenue of $947.7 million, adjusted EBITDA of $72.5 million, and adjusted EPS of $1.18, beating the midpoint of revised guidance. Management spent the call selling confidence ...
- Full-year 2025 results: revenue $947.7 million, adjusted EBITDA $72.5 million, adjusted diluted EPS $1.18, each at or above the midpoint of updated guidance.
- Large October 2025 acquisition added over 50 locations from UnitedHealth/Amedisys in the Southeast, plus Signature Healthcare at Home (closed Jan 1, 2025); management calls the Southeast deal the largest in company history and central to 2026 plans.
- 2026 full-year guidance: revenue $1.13B–$1.17B, adjusted EBITDA $88.5M–$94.1M, adjusted EBITDA prior to NCI $94.2M–$100M, adjusted EPS $1.26–$1.36; guidance assumes a phased ramp and integration noise in early quarters.
- +14 more takeaways
Cheniere Energy Fourth Quarter and Full Year 2025 Earnings Call - Completes 2020 Vision, Upsizes Buyback and Accelerates Brownfield Growth
Cheniere closed out 2025 with operational momentum and a capital-allocation mic drop. The company reported record production, strong fourth-quarter cash and earnings, and finished its 2020 Vision plan...
- Financials: Q4 consolidated adjusted EBITDA ~ $2.0 billion; FY2025 consolidated adjusted EBITDA ~ $6.94 billion (high end of guidance).
- Cash flow: Q4 distributable cash flow ~ $1.5 billion; FY2025 DCF ~ $5.3 billion, about $100 million above the high end of guidance.
- Earnings: Q4 net income ~ $2.3 billion; FY net income > $5.3 billion.
- +13 more takeaways